Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taehoon Lee

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Allergy, Asthma & Immunology Research|August 19, 2024
Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 ContinentsSo-Young Park, Stephen Fowler, Dominic E Shaw, et al.
Allergy, Asthma & Immunology Research|December 2, 2025
Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM StudyJi-Su Shim, Hyunkyoung Kim, Jae-Woo Kwon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 20, 2025
Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma StudyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Allergy, Asthma & Immunology Research|June 24, 2024
Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSARSo-Young Park, Sun-Kyung Lee, Woo-Jung Song, et al.
The World Allergy Organization Journal|September 10, 2024
Effect of biologic therapies on quality of life in severe asthma: Findings from the PRISM studyHyo-In Rhyou, Hyun-Kyoung Kim, Woo-Jung Song, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 17, 2023
Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM studyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Lung|January 22, 2024
Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM StudyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
ERJ Open Research|August 28, 2025
Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthmaDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
The World Allergy Organization Journal|December 6, 2024
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatmentDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Allergy|January 7, 2021
Characteristics of Specialist-Diagnosed Asthma-COPD Overlap in Severe Asthma: Observations from the Korean Severe Asthma Registry (KoSAR)Hyun Lee, Sang-Heon Kim, Byung-Keun Kim, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Allergy, Asthma & Immunology Research|August 19, 2024
Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 ContinentsSo-Young Park, Stephen Fowler, Dominic E Shaw, et al.
Allergy, Asthma & Immunology Research|December 2, 2025
Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM StudyJi-Su Shim, Hyunkyoung Kim, Jae-Woo Kwon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 20, 2025
Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma StudyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Allergy, Asthma & Immunology Research|June 24, 2024
Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSARSo-Young Park, Sun-Kyung Lee, Woo-Jung Song, et al.
The World Allergy Organization Journal|September 10, 2024
Effect of biologic therapies on quality of life in severe asthma: Findings from the PRISM studyHyo-In Rhyou, Hyun-Kyoung Kim, Woo-Jung Song, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 17, 2023
Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM studyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Lung|January 22, 2024
Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM StudyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
ERJ Open Research|August 28, 2025
Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthmaDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
The World Allergy Organization Journal|December 6, 2024
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatmentDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Allergy|January 7, 2021
Characteristics of Specialist-Diagnosed Asthma-COPD Overlap in Severe Asthma: Observations from the Korean Severe Asthma Registry (KoSAR)Hyun Lee, Sang-Heon Kim, Byung-Keun Kim, et al.
Pageof 17